T Scan Therapeutics
Biotechnology, 830 Winter St, Waltham, Massachusetts, 02451, United States, 51-200 Employees
Phone Number: 85********
Who is TSCAN THERAPEUTICS
TScan is dedicated to creating life-changing T cell therapies for patients by unleashing the untapped potential of the human immune system. TScan Therapeutics was founded in 2018 by a sma...
Read More
-
Headquarters: 830 Winter St, Waltham, Massachusetts, 02451, United States
-
Date Founded: 2018
-
Employees: 51-200
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
Does something look wrong? Fix it. | View contact records from TSCAN THERAPEUTICS
TScan Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding TScan Therapeutics
Answer: TScan Therapeutics's headquarters are located at 830 Winter St, Waltham, Massachusetts, 02451, United States
Answer: TScan Therapeutics's phone number is 85********
Answer: TScan Therapeutics's official website is https://tscan.com
Answer: TScan Therapeutics's revenue is $10 Million to $25 Million
Answer: TScan Therapeutics's SIC: 2836
Answer: TScan Therapeutics has 51-200 employees
Answer: TScan Therapeutics is in Biotechnology
Answer: TScan Therapeutics contact info: Phone number: 85******** Website: https://tscan.com
Answer: TScan is dedicated to creating life-changing T cell therapies for patients by unleashing the untapped potential of the human immune system. TScan Therapeutics was founded in 2018 by a small group of scientists led by Dr. Stephen Elledge (Harvard Medical School/HHMI). TScan is discovering and developing novel TCR-engineered T cell therapies for the treatment of cancer. Our discovery platform is centered around a breakthrough technology that enables the rapid, comprehensive, and genome-wide identification of the peptide antigen targets of T cell receptors. This technology greatly enhances our ability to understand the specific antigens that drive important disease processes, including tumor cell recognition by the immune system, self-reactivity in autoimmune disorders, and acquired immunity in infectious disease. TScan is using the platform in oncology to discover new TCR/target pairs and to rapidly move novel TCRs into clinical development.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month